Biotech And Pharma Stock News
Exact Sciences Stock, A Cathie Wood Darling, Tumbles On Wide Quarterly Losses
Business
Exact Sciences (EXAS) stock tumbled late Wednesday after the Cologuard maker reported wide March-quarter losses, though sales came in ahead of expectations. ...
Teva Stock Launches To A 5-Year High On An Important Development In Antipsychotics
Business
Teva stock surged to a five-year high Wednesday after the company beat first-quarter expectations and unveiled promising results from its schizophrenia treatment ...
Amgen Stock Rockets; Biotech Is ‘Very Encouraged’ With Its Obesity Study
Business
Amgen (AMGN) stock surged late Thursday after the biotech behemoth said it’s “very encouraged” with the interim results of its obesity treatment, ...
Novo Nordisk Stock Dips As Q1 Wegovy Sales Double, But Miss Target
Business
Novo Nordisk (NVO) stock eased a fraction early Thursday after the weight-loss drugs leader reported adjusted income of 81 cents per share ...
AbbVie Stock Dives Despite ‘Firing On All Cylinders’ In First Quarter
Business
AbbVie (ABBV) is “firing on all cylinders,” an analyst said Friday after the pharma giant beat Wall Street’s first-quarter expectations and raised ...
ResMed Stock Reverses Higher As Weight-Loss Drugs Seen Bolstering Its Devices
Sports
ResMed (RMD) stock jumped Thursday after an analyst suggested the growing popularity of weight-loss drugs from Eli Lilly (LLY) and Novo Nordisk ...
Vertex Pharmaceuticals Nabs Alpine Immune Sciences In $4.9 Billion Deal
Business
Analysts applauded Vertex Pharmaceuticals (VRTX) on Thursday for its acquisition of Alpine Immune Sciences (ALPN) — a $4.9 billion deal that sent ...
BioNTech Stock Hits Three-Year Low As Covid Vaccine Sales Plummet 65%, Missing Forecasts
Business
BioNTech (BNTX) stock tumbled to its lowest point in three years Wednesday after the Covid vaccine maker reported light fourth-quarter sales and ...
Weight-Loss Drugs: How Outliers Like Biohaven, Regeneron Are Taking On The Muscle Dilemma In The Obesity Space
Health
There’s room for new players in the red-hot weight-loss drugs arena, especially if they can solve a problem that continues to vex ...
Amgen Stock Slumps As It Looks To Take On Weight-Loss Drugs Leaders Lilly, Novo
Business
Amgen (AMGN) stock slumped Monday — as Eli Lilly (LLY) stock hit a record high — after the biotech company said its ...
